IGHE and Alzheimer disease: Being multifactorial and highly heterogeneous between patients, AD is primarily driven by a combination of epidermal barrier defects and immunological alterations, promoting heightened type 2 responses and IgE-mediated sensitization to various allergens (Weidinger et al., 2018).